Du må bruke en annen nettleser. For å bruke våre webtjenester kan du isteden bytte til en av disse nettleserne: Apple Safari, Google Chrome, Microsoft Edge eller Mozilla Firefox. Les mer om anbefalte nettlesere.
SEB Fund 3 - SEB Medical Fund merges with SEB Concept Biotechnology / 21 April 2023
Please be informed that the management company, SEB Investment Management, has decided to merge SEB Fund 3 - SEB Medical Fund with SEB Concept Biotechnology, the receiving fund.
The merger will be carried out 21 April 2023.
AS of now our customers have holdings for this Fund: Name: SEB Fund 3 - SEB Medical Fund ISIN: LU0047324214
Important dates:
14 April 2023: Cut-off time on this day is the last chance to sell units in the merging sub-fund;